glp 1 for cardiovascular disease Stopping GLP-1 drugs can quickly erase benefits – WashU Medicine Therapeutic Potential of GLP-1 Receptor

These include a relative or absolute increase in glucagon secretion from alpha cells of the pancreas, elevated serum free fatty-acid concentrations, an impaired incretin effect (e.g., decreased secretion of glucagon-like peptide-1 [GLP-1]), enhanced renal reabsorption of glucose, and dysregulation of appetite control via decreased neurotransmitter response in the brain

The math is straightforward

She notes that she tried out GLP-1s herself and had success before her son tried them, so she felt more comfortable with the process, especially knowing that these are not brand-new drugs and have been prescribed to adults and children with diabetes for years

Hers/Hims offers brand-name GLP-1s, as well as generic liraglutide, which is much more affordable and was approved by the FDA for weight loss in 2025

Individual experiences vary and do not guarantee eligibility, prescription approval, symptom improvement, or a specific result

This money may even be subject to federal government penalties